APA citiranje

Voruganti, S., LaCroix, J. C., Rogers, C. N., Rogers, J., Matts, R. L., & Hartson, S. D. (2013). The anti-cancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors.

Citação norma Chicago

Voruganti, Sudhakar, Jeff C. LaCroix, Chelsea N. Rogers, Janet Rogers, Robert L. Matts, and Steven D. Hartson. The Anti-cancer Drug AUY922 Generates a Proteomics Fingerprint That Is Highly Conserved Among Structurally Diverse Hsp90 Inhibitors. 2013.

MLA citiranje

Voruganti, Sudhakar, et al. The Anti-cancer Drug AUY922 Generates a Proteomics Fingerprint That Is Highly Conserved Among Structurally Diverse Hsp90 Inhibitors. 2013.